Regular Pitch Event

This is a regularly scheduled meeting for our investor members to see presentations by companies raising capital.  

This event is scheduled for Wednesday, 19-Mar-2025 from 4pm - 7:40pm PT // 7pm - 8:40pm ET. 

Proposed agenda and presenting companies are listed below.

Each presenting company will be allotted 20 minutes for pitch presentation and Member Q&A.  The final 30 minutes are dedicated to a Members Only Discussion during which members discuss each presentation, decide whether to proceed or decline, assign a deal lead, etc..

Invited companies are screened by WAA's Screening Committee and selected based on a variety of criteria. 

If you would like to recommend a company to Wharton Alumni Angels for funding consideration, please share the link for our FUNDING APPLICATION found on our website (Startup Resources => Get Funded").

* If you do not know how to or are unable to access Dealum please contact [email protected]. 

This is a video event for Wharton Alumni Angel Members only.  Full AND Associate Members are invited to attend.

Advanced registration (below) is required to attend this event.  Joining information will be included in email confirmation upon registration.

PROPOSED AGENDA:

  We're accelerating the transition towards a circular economy using consumer protein waste to create fibers & bioplastics

🔴 WAA Port Co

PROBLEM: Fashion industry accounts for 10% of global carbon emissions and produces tons of waste. Brands are looking for scalable cost efficient alternatives to hazardous fibers.

SOLUTION: We're using cost efficient waste streams in existing infrastructure of create fibers and bioplastics for the fashion industry.

DEALUM

#2-bloom_labs_ex-dropel on Slack

  Cayuga Biotech: Harnessing the body's innate ability to halt hemorrhage

🔴 WAA Port Co

PROBLEM: Hemorrhage accounts for 2 million deaths/year and is largely preventable. Uncontrolled hemorrhage is also associated with poor long-term outcomes and very high healthcare costs.

SOLUTION: Cayuga's lead drug, CAY001, was designed to address the top causes of preventable death from hemorrhage. It is a one-time IV injection that accelerates the clotting response safely. CAY001 is based on a polymer is stored in platelets and plays a role in the natural clotting process.

DEALUM

#2-cayuga-biotech on Slack

   Actuated is a multi-asset, multi-faceted MedTech innovator with a proven record, that is seeking to monetize its assets.

⭐ Sourced by KRYSTAL KARASCIK

PROBLEM: 

1. Large polyp removal via advanced endoscopy needs better tools to improve outcomes and reduce cancer recurrence
2. 1.8M feeding tubes clog impacting medication, nutrition & hydration delivery
3. Exiting first two tech packages lets us focus on long term goal of revolutionizing how neural implants are inserted & maintained to treat neural illness.

SOLUTION: 

1. GripTract has 2 fingers that slide on to the distal end of the endoscope, enhancing tissue manipulation, making procedures easier and faster.
2. TubeClear uses gentle motion to clear sluggish and clogged indwelling feeding tubes in minutes.
3. Our neuroscience tools have improved preclinical implant outcomes and are poised to move to human use.

DEALUM

#1-actuated-medical on Slack

  AI analysis tool that enables owners, coaches & agents to understand how all 22 players create impact the entire match.

⭐ Sourced by SOPHIA LEE

PROBLEM: To properly analyze a soccer match today is impossible for humans to do accurately and without bias. It's also impossible for the human eye/brain to calculate how 22 players interact with each other spatially through out a 90 minute match. Current analytics tools and existing stats are not accurate enough to give anyone true insight.

SOLUTION: Impact Soccer solves this by analyzing customers film automatically and without any human interaction. Customers simply load the film, wait, and when it is completed processing the match, they are provided results. There is no learning, we are camera agnostic (you can use a phone), customers can see and download everything.

DEALUM

#1-impact-soccer on Slack

----------

Wharton Alumni Angels is not a venture fund, an investment bank, a broker/dealer, investment clearing‐house, or an investment advisor. Wharton Alumni Angels is not registered with the U.S. Securities Exchange Commission or any other state’s or nation’s securities commission. For tax, compliance, reporting, legal or other requirements, it is highly recommended that members seek appropriate professional help. No representation or warranty is made as to the accuracy or completeness of the information provided by Wharton Alumni Angels or companies presenting investment opportunities. Wharton Alumni Angels presumes that any offering conducted by companies is a private placement and does not involve a public solicitation of investment.